Thank you, Madam Chair.
Thank you to the witnesses for being with us today.
Mr. Gallivan, last March the committee heard that CBSA is approved to spend up to $526 million on CARM. About $438 million had already been allocated and spent to date. Of that, you said that about $182 million had gone to Deloitte Canada. Are these numbers still accurate at this point in time?